These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 34287058)
21. Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals. Tserel L; Jõgi P; Naaber P; Maslovskaja J; Häling A; Salumets A; Zusinaite E; Soeorg H; Lättekivi F; Ingerainen D; Soots M; Toompere K; Kaarna K; Kisand K; Lutsar I; Peterson P Front Immunol; 2021; 12():709759. PubMed ID: 34603283 [TBL] [Abstract][Full Text] [Related]
22. Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals. Markmann AJ; Giallourou N; Bhowmik DR; Hou YJ; Lerner A; Martinez DR; Premkumar L; Root H; van Duin D; Napravnik S; Graham SD; Guerra Q; Raut R; Petropoulos CJ; Wrin T; Cornaby C; Schmitz J; Kuruc J; Weiss S; Park Y; Baric R; de Silva AM; Margolis DM; Bartelt LA mSphere; 2021 Aug; 6(4):e0027521. PubMed ID: 34431693 [TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study. Ladhani SN; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Walker J; Andrews N; Ireland G; Aiano F; Amin-Chowdhury Z; Letley L; Flood J; Jones SEI; Borrow R; Linley E; Zambon M; Poh J; Saliba V; Amirthalingam G; Lopez Bernal J; Brown KE; Ramsay ME Lancet Child Adolesc Health; 2021 Jun; 5(6):417-427. PubMed ID: 33740430 [TBL] [Abstract][Full Text] [Related]
24. Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study. Krutikov M; Palmer T; Tut G; Fuller C; Shrotri M; Williams H; Davies D; Irwin-Singer A; Robson J; Hayward A; Moss P; Copas A; Shallcross L Lancet Healthy Longev; 2021 Jun; 2(6):e362-e370. PubMed ID: 34104901 [TBL] [Abstract][Full Text] [Related]
25. Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgG. Katz MJ; Heaney CD; Pisanic N; Smith L; Bigelow BF; Sheikh F; Boudreau A; Kruczynski K; Hsu YJ; Salinas AB; Cosgrove SE; Rock C J Am Geriatr Soc; 2022 Mar; 70(3):659-668. PubMed ID: 35038344 [TBL] [Abstract][Full Text] [Related]
26. Antibody Seroprevalence, Infection and Surveillance for SARS-CoV-2 in Residents and Staff of New Jersey Long-Term Care Facilities. Friedman SM; Davidow AL; Gurumurthy M; Peymani R; Webb J; Desai K; Siderits R; Nepomich A; Lifshitz E; Thomas PA J Community Health; 2022 Oct; 47(5):774-782. PubMed ID: 35704225 [TBL] [Abstract][Full Text] [Related]
27. Optimizing COVID-19 surveillance in long-term care facilities: a modelling study. Smith DRM; Duval A; Pouwels KB; Guillemot D; Fernandes J; Huynh BT; Temime L; Opatowski L; BMC Med; 2020 Dec; 18(1):386. PubMed ID: 33287821 [TBL] [Abstract][Full Text] [Related]
28. Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants. Ibarrondo FJ; Hofmann C; Ali A; Ayoub P; Kohn DB; Yang OO mBio; 2021 Dec; 12(6):e0265621. PubMed ID: 34872349 [TBL] [Abstract][Full Text] [Related]
29. Remote infection control assessments in long-term care facilities during COVID-19 pandemic in Texas, 2020. Singer R; Rodriguez G; Garcia B; Nutt A; Merengwa E Am J Infect Control; 2022 Oct; 50(10):1110-1117. PubMed ID: 36150795 [TBL] [Abstract][Full Text] [Related]
30. Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening". Jin DK; Nesbitt DJ; Yang J; Chen H; Horowitz J; Jones M; Vandergaast R; Carey T; Reiter S; Russell SJ; Kyratsous C; Hooper A; Hamilton J; Ferreira M; Deng S; Straus D; Baras A; Hillyer CD; Luchsinger LL PLoS One; 2021; 16(4):e0250319. PubMed ID: 33909646 [TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays. Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N; Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976 [TBL] [Abstract][Full Text] [Related]
32. A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies. Solastie A; Virta C; Haveri A; Ekström N; Kantele A; Miettinen S; Lempainen J; Jalkanen P; Kakkola L; Dub T; Julkunen I; Melin M Microbiol Spectr; 2021 Dec; 9(3):e0113121. PubMed ID: 34787485 [TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan. Valenti L; Bergna A; Pelusi S; Facciotti F; Lai A; Tarkowski M; Lombardi A; Berzuini A; Caprioli F; Santoro L; Baselli G; Ventura CD; Erba E; Bosari S; Galli M; Zehender G; Prati D; Blood Transfus; 2021 May; 19(3):181-189. PubMed ID: 33539289 [TBL] [Abstract][Full Text] [Related]
34. Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection. Lapp SA; Edara VV; Lu A; Lai L; Hussaini L; Chahroudi A; Anderson LJ; Suthar MS; Anderson EJ; Rostad CA PLoS One; 2021; 16(8):e0256482. PubMed ID: 34449792 [TBL] [Abstract][Full Text] [Related]
35. Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection. Yang Y; Yang M; Peng Y; Liang Y; Wei J; Xing L; Guo L; Li X; Li J; Wang J; Li M; Xu Z; Zhang M; Wang F; Shi Y; Yuan J; Liu Y Nat Microbiol; 2022 Mar; 7(3):423-433. PubMed ID: 35132197 [TBL] [Abstract][Full Text] [Related]
36. Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China. Feng X; Yin J; Zhang J; Hu Y; Ouyang Y; Qiao S; Zhao H; Zhang T; Li X; Zhang L; Zhang J; Jin R; Feng Y; Su B Front Immunol; 2021; 12():614436. PubMed ID: 33790892 [TBL] [Abstract][Full Text] [Related]
37. A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array. Fisher M; Levy H; Fatelevich E; Afrimov Y; Ben-Shmuel A; Rosenfeld R; Noy-Porat T; Glinert I; Sittner A; Biber A; Belkin A; Bar-David E; Puni R; Levy I; Mazor O; Weiss S; Mechaly A Microbiol Spectr; 2021 Oct; 9(2):e0087021. PubMed ID: 34612689 [TBL] [Abstract][Full Text] [Related]
38. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection. Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM Elife; 2022 Jan; 11():. PubMed ID: 35072628 [TBL] [Abstract][Full Text] [Related]
39. Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection. Ramos I; Goforth C; Soares-Schanoski A; Weir DL; Samuels EC; Phogat S; Meyer M; Huang K; Pietzsch CA; Ge Y; Pike BL; Regeimbal J; Simons MP; Termini MS; Vangeti S; Marjanovic N; Lizewski S; Lizewski R; George MC; Nair VD; Smith GR; Mao W; Chikina M; Broder CC; Laing ED; Bukreyev A; Sealfon SC; Letizia AG Front Immunol; 2021; 12():681586. PubMed ID: 34177926 [TBL] [Abstract][Full Text] [Related]
40. Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients. Liao B; Chen Z; Zheng P; Li L; Zhuo J; Li F; Li S; Chen D; Wen C; Cai W; Wu S; Tang Y; Duan L; Wei P; Chen F; Yuan J; Yang J; Feng J; Zhao J; Zhao J; Sun B; Zhu A; Li Y; Tang X Front Immunol; 2021; 12():724763. PubMed ID: 34489978 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]